藍帆醫療(002382.SZ)75億隻丁腈手套項目建成達產
藍帆醫療(002382.SZ)4月28日晚間公吿,公司年產75億支健康防護(丁腈)手套項目已經建設完工,部分生產線開始試生產。
據公吿,該產線於2020年下半年開工建設,近日已經順利產出合格的丁腈手套產品,實現正常生產,後續該項目其他生產線將陸續投產。據悉,該產線投產進度迅速,相對同業耗時明顯較短,公司行動力、執行力可見一斑。
公司表示,該項目建成達產後,有助於緩解產能緊張,充分發揮出公司的核心競爭優勢,進一步提高公司醫療及防護手套的產能,增強公司行業競爭能力和盈利能力。
鑑於全球各地疫情仍未緩解,國外疫情對醫療及健康防護手套需求持續增加,公司在山東濰坊投資建設的“200億支/年高端健康防護丁腈手套項目”一期(100億支/年)、“45億支/年PVC健康防護手套項目”正在全力推進中,預計將於2021年年中投產。
上述項目建成達產後,藍帆醫療手套產品品類、佈局、覆蓋區域將更加全面合理。同時,手套產品的產能得到釋放後,能夠更有效地滿足全球客户需求,將進一步夯實公司的國際市場份額,有利於保障公司未來的年度業績增長,對公司後續發展有積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.